Relationship between apo(a) length polymorphism and lipoprotein(a) concentration in healthy Ivorian subjects with single or double apo(a) isoforms

Clinical Biochemistry

Volumn 41, Issue 13, 2008, Pages 1039-1043

  Edjème Aké, Angèle ^a,b   Garnotel, Roselyne ^d,e   Vallée Polneau, Sandrine ^c   Anglés Cano, Eduardo ^f   Monnet, Dagui ^a   Gillery, Philippe ^d,e  

^a Falculty of Pharmacy   (Côte d’Ivoire)

^b INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^c Laboratory of Biophysics and Statistics   (Côte d’Ivoire)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e CNRS   (France)

^f UNIVERSITÉ DE CAEN   (France)

Author keywords

Apo(a) isoforms; Apo(a) size; Healthy subjects; Ivory Coast; Lipoprotein (a); Polymorphism

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); DNA POLYMORPHISM; ELETROIMMUNODIFFUSION; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOPHELOMETRY; LIPOPROTEIN BLOOD LEVEL; MALE; METHODOLOGY; NORMAL DISTRIBUTION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; APOLIPOPROTEINS A; COTE D'IVOIRE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS;

EID: 49549091987     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.05.014     Document Type: Article

References (29)

1. Berg K. A new serum type system in man. The LP system. Acta Pathol. Microbiol. Scand. 59 (1963) 369-382
2. Lackner C., Cohen J.C., and Hobbs H.H. Molecular definition of the extreme size polymorphism in apolipoprotein (a). Hum. Mol. Genet. 2 (1993) 933-940
3. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330 (1987) 132-137
4. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., and Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80 (1987) 458-465
5. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., and Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90 (1992) 52-60
6. Nazir D.J., Hill S.A., and McQueen M.J. Biological variation in lipoprotein(a). Clin. Chem. Lab. Med. 37 (1999) 85
7. Enas E.A., Chacko V., Sentilkumar A., Puthumana N., and Mohan V. Elevated lipoprotein(a)- a genetic risk factor for premature vascular disease in people with and without standard risk factors. A Review. Dis. Mon. 52 (2006) 5-50
8. Gaw A., Boerwinkle E., Cohen J.C., and Hobbs H.H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no commun "nul" allele at the apo(a) locus. J. Clin. Invest. 93 (1994) 2526-2534
9. Monnet D., Edjème N.A., Ndri K., Hauhouot-Attoungbre M.L., Ahibo H., Sangare A., et al. The lipoprotein(a) and acute phase inflammation proteins during homozygous drepanocytosis. Ann. Biol. Clin. 60 (2002) 101-103
10. Tiahou G., Aveynier E., Djessou P., Sess D., and Cristol J.P. Study of Lp(a) phenotype in Ivorian subjects. Bull. Soc. Pathol. Exot. 98 (2005) 99-103
11. Dahlen G.H., Guyton J.R., Attar M., Farmer J.A., Kautz J.A., and Gotto Jr. A.M. Association of levels of lipoprotein Lp(a), plasma lipids, and others lipoproteins with coronary artery disease documented by angiography. Circulation 74 (1986) 758-765
12. Koschinsky M.L. Lipoprotein(a) and the link between atherosclerosis and thrombosis. Can. J. Cardiol. 20 Suppl B (2004) 37B-43B
13. Marcovina S.M., and Koschinsky M.L. Lipoprotein(a) concentration and apolipoprotein(a) size. A synergistic role in advanced atherosclerosis?. Circulation 100 (1999) 1151-1153
14. Paultre F., Pearson T.A., Weil H.F., Tuck C.H., Myerson M., Rubin J., et al. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2619-2624
15. Marcovina S.M., Zhang Z.H., Gaur V.P., and Albers J.J. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem. Biophys. Res. Commun. 191 (1993) 1192-1196
16. Dube N., Voorbi J.R., Leus F., and Gomo Z.A. Lipoprotein(a) concentrations and apolipoprotein (a) isoform distribution in Zimbabwean population. Cent. Afr. J. Med. 48 (2002) 83-87
17. Ali S., Bunker C.H., Aston C.E., Ukoli F., and Kamboh M.I. Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks. Hum. Biol. 70 (1998) 477-490
18. Gillery P., Arthuis P., Cuperlier C., and Circaud R. Rate nephelometric assay of serum lipoprotein (a). Clin. Chem. 39 (1993) 503-508
19. Laurell C.B. Electroimmunoassay. Scand. J. Clin. Lab. Invest. 124 (1972) 21-37
20. Kostner G.M., Gries A., Pometta M., Molinari E., Pichler P., and Aicher H. Immunochemical determination of lipoprotein Lp(a): comparison of Laurell electrophoresis and ELISA. Clin. Chim. Acta 188 (1990) 187-192
21. Anglés-Cano E., Loyau S., Cardoso-Saldana G., Couderc R., and Gillery P. A novel kringle-4 number-based recombinant apo(a) standard for human Lp(a) phenotyping. J. Lipid. Res. 40 (1999) 354-359
22. Edjème-Aké A., Garnotel R., Anglés-Cano E., Monnet D., and Gillery P. Immunoquantification of serum lipoprotein (a) in health Ivorian subject: a comparative evaluation of two methods. Ann. Biol. Clin. 65 (2007) 629-635
23. Alaoui M., Merle C., Garnotel R., Jolly D., Durlach V., and Gillery P. Study of apo(a) length polymorphism and lipoprotein(a) concentrations in subjects with single or double apo (a) isoforms. Clin. Chem. Lab. Med. 41 (2003) 634-639
24. Longenecker J.C., Klag M.J., Marcovina S.M., Liu Y.M., Jaar B.G., Powe N.R., et al. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J. Am. Soc. Nephrol. 16 (2005) 1794-1802
25. Marcovina S.M., Albers J.J., Wijsman E., Zhang Z., Chapman N.H., and Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J. Lip. Res. 37 (1996) 2569-2585
26. Gaw A., Brown E.A., and Ford I. Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations. Evidence for a threshold effect. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1870-1876
27. Rosby O., and Berg K. LPA gene: interaction between the apolipoprotein(a) size (kringle IV repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level. J. Intern. Med. 247 (2000) 139-152
28. Marcovina S.M., Koschinsky M.L., Albers J.J., and Skarlatos S. Report of the national heart, lung and blood Institute Workshop on lipoprotein(a) and cardiovascular disease: recent advances and futures directions. Clin. Chem. 49 (2003) 1785-1796
29. Rubin J., Kim H.J., Pearson T.A., Holleran S., Ramakrishnan R., and Berglund L. Apo(a) size and PNR explain African American-Caucasian differences in allele-specific apo(a) levels for small but not large apo(a). J. Lipid Res. 47 (2006) 982-989